Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01882803
Brief Title: A Phase 2 Study of Duvelisib in Subjects With Refractory Indolent Non-Hodgkin Lymphoma (DYNAMO)

First Submitted : May 31, 2013
First Submitted that Met QC Criteria : June 18, 2013
First Posted : June 20, 2013 (Estimate)

Results First Submitted : October 23, 2018
Results First Submitted that Met QC Criteria : October 23, 2018
Results First Posted : November 20, 2018

Certification/Extension First Submitted : May 11, 2017
Certification/Extension First Submitted that Met QC Criteria : May 11, 2017
Certification/Extension First Posted : May 12, 2017

Last Update Submitted that Met QC Criteria : May 13, 2020
Last Update Posted : May 15, 2020